Institutional Biosafety Committee (IBC)

The OUHSC Institutional Biosafety Committee (IBC) has the charge of reviewing and approving the biological safety of all OUHSC and OU-Tulsa basic and clinical research activities involving recombinant DNA, gene transfer including transfer to humans, microorganisms, viruses, and biological toxins.

IBC Links:

• IBC Policies
• Forms
• Organism/Virus/Toxin Inventory Submission

  (To acces this website, the PI must enter his/her OUHSC username and password at the login prompt.  A technician may enter the data for the PI, but the PI must login to the system to receive credit)

• Meeting/Deadline Dates
  

• National Institutes of Health (NIH) Guidelines for Research Involving Recombinant DNA Molecules (full text) (summary)
• Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) Biosafety in Microbiological and Biomedical Labs (full text) (summary)
• CDC/United States Department of Agriculture (USDA) Select Agent Program (information and forms)
• National Institutes of Health (NIH) Lentivirus Guidelines
• Stanford University Guidelines for Working with Viral Vectors
• 32 CFR Part 626 Biological Defense Safety Program
• 32 CFR Part 627 Biological Defense Safety Program, Technical Safety Requirements (DA Pamphlet 385-69)
• Occupational Safety and Health Administration (OSHA) Bloodborne Pathogen Standard (full text) (summary)
• Occupational Safety and Health Administration (OSHA) Occupational Exposure to Hazardous Chemicals in Laboratories Standard (full text) (summary)
• Risk Group Classification for Infectious Agents American Biological Safety Organization
• Guidelines for Work With Toxins of Biological Origin Centers for Disease Control and Prevention
• Laboratory Security and Emergency Response Guidance for Laboratories Working with Select Agents Centers for Disease Control and Prevention
• NIH Guidance on Informed Consent For Gene Transfer Research National Institutes of Health Office of Biotechnoloy Activities